Morgan Stanley’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Buy
367,021
+20,279
+6% +$30.3K ﹤0.01% 5513
2026
Q1
$531K Sell
346,742
-25,887
-7% -$34K ﹤0.01% 5456
2025
Q4
$462K Sell
372,629
-70,429
-16% -$98.6K ﹤0.01% 5555
2025
Q3
$895K Buy
443,058
+56,534
+15% +$104K ﹤0.01% 5227
2025
Q2
$696K Sell
386,524
-93,556
-19% -$180K ﹤0.01% 5292
2025
Q1
$1.02M Buy
480,080
+17,722
+4% +$60.4K ﹤0.01% 4986
2024
Q4
$1.79M Sell
462,358
-44,453
-9% -$354K ﹤0.01% 4783
2024
Q3
$5.12M Buy
506,811
+39,866
+9% +$259K ﹤0.01% 3946
2024
Q2
$2.1M Buy
466,945
+9,524
+2% +$96.8K ﹤0.01% 4533
2024
Q1
$6.84M Sell
457,421
-20,981
-4% -$345K ﹤0.01% 3654
2023
Q4
$6.95M Buy
478,402
+246,937
+107% +$3M ﹤0.01% 3651
2023
Q3
$3.18M Buy
231,465
+120,223
+108% +$2.17M ﹤0.01% 4063
2023
Q2
$2.44M Sell
111,242
-5,979
-5% -$187K ﹤0.01% 4291
2023
Q1
$3.64M Buy
117,221
+1,017
+0.9% +$12.6K ﹤0.01% 4041
2022
Q4
$980K Buy
116,204
+12,979
+13% +$111K ﹤0.01% 4883
2022
Q3
$1.01M Sell
103,225
-18,084
-15% -$208K ﹤0.01% 4876
2022
Q2
$1.45M Buy
121,309
+102,949
+561% +$603K ﹤0.01% 4762
2022
Q1
$82K Sell
18,360
-8,669
-32% -$56.2K ﹤0.01% 6446
2021
Q4
$201K Buy
27,029
+18,374
+212% +$194K ﹤0.01% 6070
2021
Q3
$103K Buy
8,655
+141
+2% +$1.79K ﹤0.01% 6356
2021
Q2
$133K Buy
+8,514
New +$150K ﹤0.01% 6213

Other funds holding BMEA

Morgan Stanley's BMEA Position: Q2 2026 in Review

Morgan Stanley increased its Biomea Fusion (BMEA) stake by 5.8% in Q2 2026, buying an estimated $30.3K and bringing the position to 367,021 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #5513.

Morgan Stanley first reported a position in BMEA in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.95M in Q4 2023. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Morgan Stanley held 367,021 shares of Biomea Fusion worth $540K as of Q2 2026.
  • Morgan Stanley bought 20,279 Biomea Fusion shares in Q2 2026, an estimated $30.3K.
  • Biomea Fusion made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5513 holding.
  • Morgan Stanley first reported a position in Biomea Fusion in Q2 2021 and has held it in 21 quarters since.
  • Morgan Stanley's Biomea Fusion position peaked at $6.95M in Q4 2023.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.